Evogene Ltd.
P.O. Box 2100
Rehovot
76121
Tel: 972-8-9311900
Fax: 972-8-9466724
Website: http://www.evogene.com/
Email: info@evogene.com
183 articles about Evogene Ltd.
-
Evogene Amends its Collaboration Agreement With Bayer to Include Genome Editing Targets
7/16/2019
Amended agreement follows positive results in corn stalk rot fungal disease control
-
Evogene to Present at Jefferies 2019 Industrials Conference
7/15/2019
Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced that Ofer Haviv, Evogene's President and CEO, will present at the Jefferies 2019 Industrials Conference taking place in New York City, August 6-8, 2019.
-
Evogene Financial Results for the Second Quarter of 2019 Earnings Announcement Schedule
7/11/2019
Evogene Ltd.,, a leading biotechnology company developing novel products for life science markets, announced that it will release its financial results for the second quarter of 2019 on Wednesday, July 31, 2019.
-
Lavie Bio Announces Positive 2nd Year Field Results in Its Bio-stimulant Program for Wheat
7/10/2019
Product candidates have repeated significant yield improvement in second year spring wheat field trials across multiple locations, varieties and conditions
-
Evogene Reports First Quarter of 2019 Financial Results
5/28/2019
Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced its financial results for the first quarter ending March 31, 2019.
-
Evogene Financial Results for the First Quarter of 2019
5/7/2019
Evogene Ltd announced that it will release its financial results for the first quarter of 2019 on Tuesday, May 28, 2019.
-
Evogene Files Annual Report for the Year Ended December 31, 2018
4/30/2019
Evogene Ltd. announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2018 with the U.S. Securities and Exchange Commission.
-
Evogene to Develop Next Generation Medical Cannabis Products Through New Subsidiary - Canonic Ltd
4/3/2019
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it has established a new subsidiary – Canonic Ltd – to develop next generation medical cannabis products.
-
Evogene to Participate in the World Agritech, Innovation Summit in San Francisco in March 19-20, 2019
3/14/2019
Ido Dor, CEO of Lavie Bio, will participate in a panel on Ag-Biologicals; in addition, Eran Kosover, CEO of AgPlenus will host a round table on collaborations in the field [14-March-2019] REHOVOT, Israel , March 1 4 , 2019 /PRNewswire/ -- - Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company devel
-
AgPlenus - Evogene's Ag-Chemicals Subsidiary - Announces the Nomination of Three Industry Leaders From the Field of Crop Protection to Its Board of Directors
3/14/2019
The nomination of these experts is expected to significantly support the company in the execution of its strategy
-
Evogene Reports Fourth Quarter and Full Year 2018 Financial Results
3/13/2019
Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced its financial results for the fourth quarter and full year ending December 31, 2018.
-
Evogene Fourth Quarter and Full Year of 2018 Earnings Announcement Schedule
2/28/2019
Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced that it will release its financial results for the fourth quarter and full year of 2018 on Wednesday, March 13, 2019.
-
Evogene Announces Establishment of Ag-Biologicals Subsidiary - LaVie Bio Ltd.
2/26/2019
Evogene's activities relating to discovery, optimization and development of sustainable ag-biological products are being transferred to the new subsidiary
-
Evogene Appoints Dr. Adrian Percy to Its Board of Directors
2/4/2019
Dr. Percy most recently served as Head of Research & Development for the Crop Science division of Bayer and has broad senior management experience in the agricultural industry
-
Evogene Financial Results for the Fourth Quarter and Full Year 2017 Earnings Announcement Schedule
2/12/2018
The Company’s management will host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. T
-
Evogene to Participate in Israeli Consortium to Develop Phenotyping Tools and Systems for Precision Agriculture
1/29/2018
Multi-year Phenomics Consortium sponsored by Israel Innovation Authority includes 10 leading companies and academic institutions.
-
Evogene Announces Positive 2nd Year Field Trial Results in Corn Bio-Stimulant Ag-Biologicals Program
1/10/2018
Results demonstrated significant yield improvement; selected microbial strains to be tested as part of the collaboration with DuPont-Pioneer.
-
Evogene Financial Results for the Third Quarter of 2017 Earnings Announcement Schedule
11/2/2017
On the day of the announcement, the Company’s management will host a conference call to discuss the results at 09:00 AM ET.
-
Evogene Ltd. & Rahan Meristem Announce Positive Results In 2nd Year Field Trials Addressing Black Sigatoka Disease In Banana And The Utilization Of The Results For Genome Editing
9/26/2017
-
Evogene Ltd. Reports Second Quarter 2017 Financial Results
8/10/2017